Gen-Probe, Tepnel deal

Gen-Probe will acquire diagnostic company Tepnel for 27.1p per share, or about £92.8 million ($127.2 million) in cash. The price is a 32% premium to Tepnel's close of 20.5p Jan. 29, the day before the...